miR-194-5p/BCLAF1 deregulation in AML tumorigenesis-Reference-Cited by-同舟云学术

miR-194-5p/BCLAF1 deregulation in AML tumorigenesis

Published:2017-02-20 Issue:11 Volume:31 Page:2315-2325
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Dell'Aversana C,Giorgio C,D'Amato L,Lania G,Matarese F,Saeed S,Di Costanzo A,Belsito Petrizzi V,Ingenito C,Martens J H A,Pallavicini I,Minucci S,Carissimo A,Stunnenberg H G,Altucci L^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201764.pdf

Reference51 articles.

1. Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233.

2. Gangaraju VK, Lin H . MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 2009; 10: 116–125.

3. Lieberman J, Slack F, Pandolfi PP, Chinnaiyan A, Agami R, Mendell JT . Noncoding RNAs and cancer. Cell 2013; 153: 9–10.

4. Song SJ, Pandolfi PP . MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemia. Curr Opin Hematol 2014; 21: 276–282.

5. Dell’aversana C, Altucci L . miRNA-mediated deregulation in leukemia. Front Genet 2012; 3: 252.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation;Cancer Letters;2024-06

2. Pan-Cancer Analysis Identifies BCLAF1 as a Potential Biomarker for Renal Cell Carcinoma;Biochemical Genetics;2024-04-04

3. miRNAs in epilepsy: A review from molecular signatures to therapeutic intervention;International Journal of Biological Macromolecules;2024-04

4. Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors;Epigenetics;2024-02-18

5. BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma;Cellular and Molecular Life Sciences;2024-02-10